Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2012
Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cellsWon Fen Wong, Kazuyoshi Kohu, Akira Nakamura, et al.Chest|October 26, 2013
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapyRyushi Tazawa, Yoshikazu Inoue, Toru Arai, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|November 16, 2014
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosisKeiichi Akasaka, Takahiro Tanaka, Takashi Maruyama, et al.Respiratory Medicine|November 25, 2011
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosisKazumasa Ohashi, Atsuyasu Sato, Toshinori Takada, et al.Infectious Diseases (London, England)|September 20, 2023
Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialShigeki Shimasaki, Tomohisa Baba, Takashi Ogura, et al.Annals of the American Thoracic Society|May 11, 2017
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar ProteinosisSayoko Tokura, Masanori Akira, Tomohisa Okuma, et al.Annals of the American Thoracic Society|August 12, 2016
Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with LymphangioleiomyomatosisToshinori Takada, Ayako Mikami, Nobutaka Kitamura, et al.American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosisRyushi Tazawa, Bruce C Trapnell, Yoshikazu Inoue, et al.The Journal of Infectious Diseases|May 2, 2009
Identification of MICA as a susceptibility gene for pulmonary Mycobacterium avium complex infectionJunko Shojima, Goh Tanaka, Naoto Keicho, et al.Pageof 13